- Alexander von Humboldt Association of America
- LES (Germany)
- VPP (Germany)
Managing Partner at Grüneberg and Myers PLLC
Kirsten A Grüneberg recently established the Grüneberg and Myers firm with several colleagues from her former medium-sized IP boutique, aiming to provide high-quality service while maximising efficiency and minimising internal bureaucracy and expenses. With a business model differing from many traditional law firms, Grüneberg and Myers is highly adaptable to the economic requirements of corporate clients. Dr Grüneberg leads a team of professionals with over 70 years’ combined experience in IP law, bolstering their ability to deliver on these goals.
Dr Grüneberg supports many of the world’s largest chemical, biotech and pharmaceutical companies in addressing their IP and business needs. She counsels clients in freedom-to-operate opinions, prosecution, portfolio management and post-grant proceedings, including inter partes reviews and re-examination. Dr Grüneberg also has significant experience with IP issues in mergers and acquisitions in the United States, Europe and Asia. Dr Grüneberg has successfully defended high-value pharmaceutical patents in post-grant proceedings, helping to secure business deals worth several hundred million dollars. She is also active on the post-grant petitioner side.
Dr Grüneberg regularly visits clients in Europe and Asia, updating them about the latest developments in US patent law and working closely with them on selected high-profile projects. With experience as head of the European practice at her former firm, Dr Grüneberg possesses an acute ability to address US patent matters for European practitioners.
After receiving her PhD in organic chemistry, magna cum laude, from the Technical University of Berlin, Dr Grüneberg was awarded a Lynen-Fellowship from the Alexander von Humboldt Foundation in Germany to perform research at the Centre for Bio/Molecular Science and Engineering at the US Naval Research Laboratory. She was a visiting professor at Georgetown University Medical Centre in Washington DC. She also worked as a senior scientist at Geo-Centres, Inc and the US Naval Research Laboratory and as a research scientist at the Max Planck Institute of Colloids and Interfaces in Berlin.